Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
Conditions: Rhegmatogenous Retinal Detachment; Proliferative Vitreoretinopathy Intervention: Drug: Netarsudil Ophthalmic Sponsor: Massachusetts Eye and Ear Infirmary Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials